Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data

European Journal of Cancer

Volumn 46, Issue 15, 2010, Pages 2788-2798

  Guastadisegni, Cecilia ^a   Colafranceschi, Mauro ^a   Ottini, Laura ^b   Dogliotti, Eugenia ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Colorectal cancer; Fluorouracil; Meta analysis; Microsatellite instability; Prognosis

Indexed keywords

FLUOROURACIL; MOLECULAR MARKER;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE FREE SURVIVAL; DRUG CYTOTOXICITY; HUMAN; META ANALYSIS; MICROSATELLITE INSTABILITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FLUOROURACIL; HUMANS; MICROSATELLITE INSTABILITY; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77957197346     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.05.009     Document Type: Article

References (85)

1. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Colon cancer survival rates with the new American joint committee on cancer sixth edition staging J Natl Cancer Inst 96 2004 1420 1425 (Pubitemid 39429665)
2. J.R. Jass Molecular heterogeneity of colorectal cancer: implications for cancer control Surg Oncol 16 Suppl. 1 2007 S7 S9
3. W.M. Grady, and S. Markowitz Genomic instability and colorectal cancer Curr Opin Gastroenterol 16 2000 62 67 (Pubitemid 30398611)
4. W.M. Abdel-Rahman, J.P. Mecklin, and P. Peltomäki The genetics of HNPCC: application to diagnosis and screening Crit Rev Oncol Hematol 58 2006 208 220 (Pubitemid 43796078)
5. C.R. Boland, S.N. Thibodeau, and S.R. Hamilton A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 1998 5248 5257
6. W.S. Samowitz, K. Curtin, and K.N. Ma Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level Cancer Epidemiol Biomarkers Prev 10 2001 917 923 (Pubitemid 32844897)
7. M.A. Jenkins, S. Hayashi, and A.M. O'Shea Colon cancer family registry. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study Gastroenterology 133 2007 48 56 (Pubitemid 47039240)
8. K. Söreide, E.A. Janssen, H. Söiland, H. Körner, and J.P. Baak Microsatellite instability in colorectal cancer Br J Surg 93 2006 395 406
9. C.I. Müller, K. Schulmann, and A. Reinacher-Schick AIO Colorectal Study Group Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group Int J Colorectal Dis 23 2008 1033 1039
10. S. Popat, R. Hubner, and R.S. Houlston Systematic review of microsatellite instability and colorectal cancer prognosis J Clin Oncol 23 2005 609 618 (Pubitemid 46224239)
11. R. Jover, P. Zapater, and A. Castells The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status Eur J Cancer 45 2009 365 373
12. Breslow NE, Day NE. Statistical methods in cancer research: the analysis of case-control studies, vol. 1. Lyon: IARC Scientific Publications; 1980.
13. S. Lee, N.Y. Cho, and M. Choi Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation Pathol Int 58 2008 104 113
14. I. Storojeva, J.L. Boulay, and K. Heinimann Prognostic and predictive relevance of microsatellite instability in colorectal cancer Oncol Rep 14 2005 241 249
15. C.M. Wright, O.F. Dent, and M. Barker Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer Br J Surg 87 2000 1197 1202
16. S. Kakar, S. Aksoy, L.J. Burgart, and T.C. Smyrk Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival Mod Pathol 17 2004 696 700 (Pubitemid 38715493)
17. P.L. Barratt, M.T. Seymour, and S.P. Stenning DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study Lancet 360 2002 1381 1391
18. P. Benatti, R. Gaf, and D. Barana Microsatellite instability and colorectal cancer prognosis Clin Cancer Res 11 2005 8332 8340 (Pubitemid 41746945)
19. W.G. Cochran The combination of estimates from different experiments Biometrics 10 1954 101 129
20. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Controlled Clin Trials 7 1986 177 188 (Pubitemid 17189972)
21. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
22. R. Tang, J.Y. Wang, and C.W. Fan P53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy Cancer Lett 210 2004 101 109 (Pubitemid 38692594)
23. A. Lievre, C. Chapusot, and A.M. Bouvier Clinical value of mitochondrial mutations in colorectal cancer J Clin Oncol 23 2005 3517 3525 (Pubitemid 46243496)
24. A.M. Fernandez-Peralta, N. Nejda, and S. Oliart Significance of mutations in TGFBR2 and BAX in neoplastic progression and patient outcome in sporadic colorectal tumours with high-frequency microsatellite instability Cancer Genet Cytogenet 157 2005 18 24 (Pubitemid 40164853)
25. W. Mesker, J. Junggeburt, and K. Szuhai The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumour stage Cell Oncol 29 2007 387 398 (Pubitemid 47255977)
26. D. English, J. Young, and J. Simpson Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype Cancer Epidemiol Biomarkers Prev 17 2008 1774 1780
27. J. Chan, J. Meyerhardt, and D. Niedzwiecki Association of family history with cancer recurrence and survival among patients with stage III colon cancer JAMA 299 2008 2515 2523 (Pubitemid 351787207)
28. S. Ogino, K. Shima, and Y. Baba Colorectal cancer expression of PPARG (peroxisome proliferator-activated receptor-γ) is associated with good prognosis Gastroenterology 136 2009 242 250
29. F. Prall, T. Dührkop, and V. Weirich Prognostic role of CD8+ tumour-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability Hum Pathol 35 2004 808 816 (Pubitemid 38903073)
30. L. Barault, C. Charon-Barra, and V. Jooste Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases Cancer Res 68 2008 8541 8546
31. M. Koopman, G.A. Kortman, and L. Mekenkamp Deficient mismatch repair system in patients with sporadic advanced colorectal cancer Br J Cancer 100 2009 266 273
32. M.J. Massa, P. Iniesta, and R. Gonzalez-Quevedo Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer Eur J Cancer 35 1999 1776 1782 (Pubitemid 30050639)
33. I. Zlobec, K. Baker, L. Terracciano, and A. Lugli RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis Clin Cancer Res 14 2008 3798 3806
34. T. Løvig, S.N. Andersen, and L. Thorstensen Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis Br J Cancer 87 2002 756 762 (Pubitemid 35178753)
35. J.T. Liang, K.C. Huang, and H.S. Lai High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection Int J Cancer 101 2002 519 525
36. M.L. Bisgaard, A.C. Jäger, and P. Dalgaard Allelic loss of chromosome 2p21-16.3 is associated with reduced survival in sporadic colorectal cancer Scand J Gastroenterol 4 2001 405 409 (Pubitemid 32250737)
37. M. Colombino, A. Cossu, and A. Manca Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma Ann Oncol 13 2002 1447 1453
38. A. Hemminki, J.P. Mecklin, H. Jarvinen, L.A. Aaltonen, and H. Joensuu Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy Gastroenterology 119 2000 921 928
39. S. Ogino, K. Nosho, and J. Meyerhardt Cohort study of fatty acid synthase expression and patient survival in colon cancer J Clin Oncol 26 2008 5713 5720
40. S. Ogino, G. Kirkner, and K. Nosho Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer Clin Cancer Res 14 2008 8221 8227
41. R. Jover, P. Zapater, and A. Castells Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer Gut 55 2006 848 855 (Pubitemid 43764557)
42. R.L. Ward, K. Cheong, and S.L. Ku Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability J Clin Oncol 21 2003 3729 3736 (Pubitemid 46606226)
43. H. Elsaleh, B. Powell, and P. Soontrapornchai P53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Duke's C colon carcinoma Oncology 58 2000 52 59 (Pubitemid 30045310)
44. K.C. Halling, A.J. French, and S.K. McDonnell Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers J Nat Cancer Inst 91 1999 1295 1303 (Pubitemid 29387571)
45. J.T. Liang, K.J. Chang, and J.C. Chen Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection Hepatogastroenterology 46 1999 883 890
46. R. Gaf, I. Maestri, and M. Matteuzzi Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability Cancer 89 2000 2025 2037
47. R. Gryfe, H. Kim, and E. Hsieh Tumour microsatellite instability and clinical outcome in young patients with colorectal cancer N Engl J Med 342 2000 69 77 (Pubitemid 30036597)
48. H. Elsaleh, and B. Iacopetta Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma Clin Colorectal Cancer 1 2001 104 109 (Pubitemid 32708690)
49. T. Watanabe, T.T. Wu, and P.J. Catalano Molecular predictors of survival after adjuvant chemotherapy for colon cancer N Engl. J Med 344 2001 1196 1206 (Pubitemid 32319494)
50. W.M. Brueckl, C. Moesch, and T. Brabletz Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy Anticancer Res 23 2003 1773 1777 (Pubitemid 36750847)
51. C.M. Ribic, D.J. Sargent, and M.J. Moore Tumour microsatellite- instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 2003 247 257
52. J.M. Carethers, E.J. Smith, and C.A. Behling Use of 5-Fluorouracil and survival in patients with microsatellite-unstable colorectal cancer Gastroenterology 126 2004 394 401 (Pubitemid 38182296)
53. J.L. Westra, M. Schaapveld, and H. Hollema Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients J Clin Oncol 23 2005 5635 5643 (Pubitemid 46300159)
54. W.S. Samowitz, C. Sweeney, and J. Herrick Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancer Cancer Res 65 2005 6063 6070 (Pubitemid 40994390)
55. R.L. Ward, J. Turner, and R. Williams Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified J Pathol 207 2005 377 384 (Pubitemid 43025685)
56. S.H. Chang, J.K. Lin, and S.H. Yang Relationship between genetic alterations and prognosis in sporadic colorectal cancer Int J Cancer 118 2006 1721 1727 (Pubitemid 43376435)
57. W. Dietmaier, M. Bettstetter, and P.J. Wild Nuclear Maspin expression is associated with response to adjuvant 5-fluoruracil based chemotherapy in patients with stage III colon cancer Int J Cancer 118 2006 2247 2254
58. G. Lanza, R. Gaf, and A. Santini Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients J Clin Oncol 24 2006 2359 2367 (Pubitemid 46630668)
59. F.A. Sinicrope, R.L. Rego, and K.C. Halling Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients Gastroenterology 131 2006 729 737
60. C. Lamberti, S. Lundin, and M. Bogdanow Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer Int J Colorectal Dis 22 2007 145 152 (Pubitemid 44964017)
61. M.L. Maestro, M. Vidaurreta, and M.T. Casla-Sanz Role of the BRAF mutations in the microsatellite instability genetic pathway in sporadic colorectal cancer Ann Surg Oncol 14 2007 1229 1236
62. G.P. Kim, L.H. Colangelo, and H.S. Wieand Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study J Clin Oncol 25 2007 767 772
63. A. Malesci, L. Laghi, and P. Bianchi Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer Clin Cancer Res 13 2007 3831 3839 (Pubitemid 47037588)
64. L. Barault, N. Veyrie, and V. Jooste Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers Int J Cancer 122 2008 2255 2259 (Pubitemid 351542328)
65. A. Banerjea, R.E. Hands, M.P. Powar, S.A. Bustin, and S. Dorudi Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence Colorectal Dis 11 2009 601 608
66. S. Ogino, K. Nosho, and G.J. Kirkner CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer Gut 58 2009 90 96
67. S. Jensen, B. Vainer, M. Kruhoffer, and J.B. Sorensen Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression BMC Cancer 9 2009 25
68. K. Søreide, A. Slewa, and P.J. Stokkeland Microsatellite instability and DNA ploidy in colorectal cancer Cancer 115 2009 271 282
69. Seiffert JE. Seer program: comparative staging guide for cancer. National Institutes of Health Publication No 93-3640;1993.
70. E. Barrow Cost analysis of biomarker testing for mismatch repair deficiency in node-positive colorectal cancer Br J Surg 95 2008 868 875
71. S. Ogino, and A. Goel Molecular classification and correlates in colorectal cancer J Mol Diagn 10 2008 13 27 (Pubitemid 351184831)
72. F.A. Sinicrope, and D.J. Sargent Clinical implications of microsatellite instability in sporadic colon cancers Curr Opin Oncol 4 2009 369 373
73. D.J. Samson, J. Seidenfeld, and B. Schmitt Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma Cancer 95 2002 361 376 (Pubitemid 34787603)
74. N.M. Lindor, L.J. Burgart, and O. Leontovich Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumours J Clin Oncol 20 2002 1043 1048 (Pubitemid 34141849)
75. J.W. Adlard, S.D. Richman, M.T. Seymour, and P. Quirke Prediction of the response of colorectal cancer to systemic therapy Lancet Oncol 3 2002 75 82 (Pubitemid 34162977)
76. M. Koopman, S. Venderbosch, I.D. Nagtegaal, J.H. van Krieken, and C.J. Punt A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned? Eur J Cancer 45 2009 1935 1949
77. C. Kunz, F. Focke, and Y. Saito Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil PLoS Biol 7 2009 e91
78. F. Fischer, K. Baerenfaller, and J. Jiricny 5-Fluorouracil is efficiently removed from DNA by the base excision and mismatch repair systems Gastroenterology 133 2007 1858 1868 (Pubitemid 350180806)
79. M. D'Errico, E. de Rinaldis, and M.F. Blasi Genome-wide expression profile of sporadic gastric cancers with microsatellite instability Eur J Cancer 45 2009 461 469
80. T. Andr, C. Boni, L. Mounedji-Boudiaf, and M. Navarro Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 23 2004 2343 2351 (Pubitemid 38702845)
81. Kim ST, Lee J, Park SH, et al. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy. Cancer Chemother Pharmacol 2009; doi:10.1007/s00280-009-1206-3.
82. D. Fink, H. Zheng, and S. Nebel In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair Cancer Res 57 1997 1841 1845 (Pubitemid 27209707)
83. J. Yang, J. Parsons, and N.H. Nicolay Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy Oncogene 29 2010 463 468
84. A. Walther, E. Johnstone, and C. Swanton Genetic prognostic and predictive markers in colorectal cancer Nat Rev Cancer 9 2009 489 499
85. B. Iacopetta, K. Kawakami, and T. Watanabe Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil responsive subgroup? Int J Clin Oncol 13 2008 498 503